Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $26.7 million.

  • AtriCure's Cash from Operations rose 3355.33% to $26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.1 million, marking a year-over-year increase of 31491.63%. This contributed to the annual value of $12.2 million for FY2024, which is 17216.77% up from last year.
  • As of Q3 2025, AtriCure's Cash from Operations stood at $26.7 million, which was up 3355.33% from $21.6 million recorded in Q2 2025.
  • AtriCure's Cash from Operations' 5-year high stood at $26.7 million during Q3 2025, with a 5-year trough of -$24.6 million in Q1 2022.
  • Moreover, its 5-year median value for Cash from Operations was $301000.0 (2021), whereas its average is $951263.2.
  • Per our database at Business Quant, AtriCure's Cash from Operations crashed by 66896.55% in 2022 and then soared by 866086.96% in 2023.
  • Over the past 5 years, AtriCure's Cash from Operations (Quarter) stood at $301000.0 in 2021, then crashed by 84.72% to $46000.0 in 2022, then surged by 8660.87% to $4.0 million in 2023, then soared by 44.81% to $5.8 million in 2024, then soared by 357.78% to $26.7 million in 2025.
  • Its last three reported values are $26.7 million in Q3 2025, $21.6 million for Q2 2025, and -$11.0 million during Q1 2025.